2.18

0.93% 0.02

Vyome Holdings Inc (HIND)

Overview News Price History Discussions Forecast

Vyome Holdings Inc stock is traded at $2.18, with a volume of 6,140. It is up +0.93% in the last 24 hours and up +0.00% over the past month. Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.

Previous Close:

$2.16

Open:

$2.17

24h Volume:

6,140

Relative Volume:

0.29

Market Cap:

$15.30M

Revenue:

$1.34M

Net Income/Loss:

$-13.49M

P/E Ratio:

-0.1757

EPS:

-12.4093

Net Cash Flow:

$-3.07M

1W Performance:

+0.93%

1M Performance:

+0.00%

6M Performance:

-15.83%

1Y Performance:

+0.00%

1-Day Range:

$2.12

$2.23

1-Week Range:

$2.12

$2.2744

52-Week Range:

$1.75

$12.87

Vyome Holdings Inc Stock (HIND) Company Profile

Name

Vyome Holdings Inc

Sector

Healthcare (1080)

Industry

Biotechnology (604)

Phone

949-429-6680

Address

1001 CALLE AMANECER, SAN CLEMENTE

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

HIND's Discussions on Twitter

Compare HIND vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HIND Vyome Holdings Inc	2.18	15.58M	1.34M	-13.49M	-3.07M	-12.41
VRTX Vertex Pharmaceuticals Inc	505.75	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.48	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.29	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	203.71	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	347.48	40.62B	5.76B	514.49M	1.10B	4.4813

Vyome Holdings Inc Stock (HIND) Latest News

Aug 12, 2026

VYOME HOLDINGS ($HIND) Releases Q2 2026 Earnings - Quiver Quantitative

Aug 12, 2026

Vyome Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 12, 2026

Vyome Holdings (HIND) posts higher H1 2026 loss as R&D spending grows - Stock Titan

Aug 12, 2026

Vyome Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 12, 2026

Aug 11, 2026

Vyome Holdings Ord Shs (HIND) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com

Aug 11, 2026

Aug 10, 2026

Vyome Holdings Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView

Aug 10, 2026

Aug 06, 2026

HIND Q2'26 Earnings: EPS estimate is (0.19) USD - TradingView

Aug 06, 2026

Jul 27, 2026

Vyome Holdings, Inc. Revenue Breakdown – NASDAQ:HIND - TradingView

Jul 27, 2026

Jul 26, 2026

Vyome Holdings (HIND) Slides 2.37%: Support and Resistance Levels in FocusSafe Entry Stocks - dars.gov.et

Jul 26, 2026